In 2023, the leukaemia therapeutics industry is expected to be worth US$15,246.7 million. By comparison, the amount was $14,504,8 million USD in 2022. Through 2033, the market is anticipated to grow at a CAGR of 7.1%. At the conclusion of the estimated timeframe, the market is anticipated to be worth US$ 30,318.5 million. An increase …